BioLargo (BLGO) – environmental solutions provider

    eröffnet am 26.08.20 22:10:08 von
    neuester Beitrag 09.10.22 17:31:09 von
    Beiträge: 126
    ID: 1.330.097
    Aufrufe heute: 0
    Gesamt: 3.917
    Aktive User: 0

    ISIN: US09065A1007 · WKN: A0MLEC · Symbol: BLGO
    +9,05 %
    +0,016 USD
    Letzter Kurs 02:10:00 Nasdaq OTC

    Beitrag zu dieser Diskussion schreiben

    • 1
    • 13

    Begriffe und/oder Benutzer



     Ja Nein
      schrieb am 09.10.22 17:31:09
      Beitrag Nr. 126 ()

      BioLargo Secures Product Recovery Management (PRM) as Channel Partner and Contract Manufacturer for BioLargo's Water Treatment Technologies
      WESTMINSTER, CA / ACCESSWIRE / October 6, 2022 / BioLargo, Inc. (OTCQB:BLGO), a developer of sustainable cleantech technologies and full-service environmental engineering company, announced that it signed a channel partnership agreement with Product Recovery Management, Inc. to sell and distribute BioLargo's water treatment systems and act as a contract manufacturer.

      Product Recovery Management (PRM) (, based out of Butner, NC, is a UL-certified equipment integrator specializing in remediation services with over 40 years of history serving customers. PRM designs and manufactures treatment systems that address a wide variety of contamination challenges in the remediation and landfill industries, including PFAS contamination. Their Butner operations include a 250,000 square foot manufacturing facility with large-scale fabrication capabilities.

      The channel partner agreement grants PRM a license to sell and distribute BioLargo's innovative water and wastewater treatment technologies, including but not limited to the Aqueous Electrostatic Concentrator (AEC), BioLargo's effective, affordable, low-waste solution for removing per- and polyfluoroalkyl substances (PFAS) from water. PRM will also be authorized to sell BioLargo's Advanced Oxidation System (AOS) technology, the energy-efficient and affordable solution for simultaneous water disinfection and micropollutant treatment.

      PRM will also be a contract manufacturer for BioLargo's water treatment technologies, including the AEC, the AOS, as well as other treatment systems designed by BioLargo (e.g., reverse osmosis systems).

      "PRM has substantial expertise and infrastructure to support the roll-out and manufacturing of our cleantech systems. This relationship will allow us to more readily meet the growing demand for our systems and expand our reach into the market. We have already begun scoping our first project together," says Randall Moore, President of BioLargo Engineering, Science & Technologies (BioLargo's engineering subsidiary -

      "BioLargo's AEC and AOS technologies are unique and valuable tools for targeted removal of tough-to-treat water contaminants including PFAS and micropollutants, both of which currently lack effective and affordable options in the marketplace. We recognized in BioLargo a commitment to serve customers with technical excellence and reliable results. We look forward to working with the BioLargo team," said Robert Phillips, Jr., President of Product Recovery Management.…
      Biolargo | 0,273 $
      schrieb am 09.09.22 20:25:02
      Beitrag Nr. 125 ()
      BioLargo bei ungefähr 1:07:50

      Benzinga All-Access | September 9th, 2022

      Biolargo | 0,274 $
      schrieb am 04.09.22 23:42:41
      Beitrag Nr. 124 ()
      Angesichts des enormen Potenzials ist die aktuelle Marktkapitalisierung immer noch sehr niedrig. Das in Zusammenarbeit mit Garratt-Callahan entwickelte Produkt „Minimal Liquid Discharge“ für die Abwasserbehandlung wird voraussichtlich bald auf den Markt kommen. G-C geht davon aus, nach der Einführung etwa 30 bis 50 Systeme pro Jahr zu verkaufen, mit einem durchschnittlichen Umsatz von 300.000 bis 500.000 US-Dollar pro System.

      Das Pet Odor Produkt "Pooph" wird voraussichtlich im vierten Quartal in die Regale großer Einzelhandelsgeschäfte wie Walmart kommen.

      Außerdem bewegt sich die PFAS-Behandlungstechnologie in Richtung Adoption. BLGO hat kürzlich den ersten Kunden für die PFAS-mitigation gewonnen und einen neuen Vertriebspartner für die PFAS-remediation gewonnen. PFAS ist offensichtlich ein Multi-Milliarden-Dollar-Geschäft und überall in den Nachrichten. Die kürzliche Einstufung von zwei PFAS als hazardous durch die EPA wird wahrscheinlich die Aufräumarbeiten beschleunigen...

      Statement: EPA targets two toxic PFAS chemicals under Superfund law
      August 26, 2022
      Hazardous designation would speed cleanup of dangerous PFOA and PFOS…
      Biolargo | 0,220 $
      schrieb am 23.08.22 20:01:53
      Beitrag Nr. 123 ()
      BioLargo sees 'a major opportunity' for PFAS unit as it reports a surge in second-quarter revenue
      August 19, 2022
      BioLargo Inc (OTCQB:BLGO) CEO Dennis Calvert takes Proactive's Stephen Gunnion through the company's second-quarter results, which show a 185% year-over-year jump in revenue to $1.32 million on the back of strong contributions from its engineering and environmental divisions.
      Calvert telling Proactive that the company's PFAS (per- and polyfluoroalkyl substances) business is a major opportunity, and BioLargo is at the forefront of real environmental impact, working with channel partners to solve some of today’s toughest environmental challenges.

      Biolargo | 0,190 $
      schrieb am 19.08.22 19:04:30
      Beitrag Nr. 122 ()

      BioLargo Achieves 185% Growth to $1.3 Million Revenue for Second Quarter 2022, as Published in Quarterly Report

      Quarterly Report highlighted by profitable operating subsidiaries, growth of white-label odor product sales, and large engineering projects

      WESTMINSTER, CA / ACCESSWIRE / August 16, 2022 / BioLargo, Inc. (OTCQB:BLGO), a developer of sustainable cleantech technologies and full-service environmental engineering company, filed its Quarterly Report on Form 10-Q for the period ended June 30, 2022, with the SEC yesterday ( Here the company has provided highlights from the quarterly report and a discussion of key business initiatives with the most potential to stimulate growth.

      BioLargo's President and CEO Dennis P. Calvert said, "We are proud of the entire BioLargo team working together and executing on all fronts as we continue growing the business through bigger and better projects. It has been incredible to watch our team land and expand into new client projects through great service and deliverables. PFAS is a major opportunity for us, and we are on the forefront of real environmental impact, working with channel partners to solve some of today's toughest environmental challenges."

      Financial highlights

      Company-wide consolidated revenue for the three and six months ended June 30, 2022, was $1,323,000 and $2,287,000, which is a 185% and 121% increase over the same periods in 2021; revenue this quarter was a 37% increase compared with the first quarter of 2022.
      Revenues from ONM Environmental, the company's odor and VOC control subsidiary, for the three and six months ended June 30, 2022, were $700,000 and $1,300,000, an increase of $344,000 and $658,000, from the same periods in 2021. In the second quarter of 2022, this subsidiary generated a net operating income of $11,000, compared to a net operating loss of $107,000 in the same period of 2021.
      Revenues from third parties for BioLargo Engineering, Science & Technologies, the company's environmental engineering subsidiary, for the three and six months ended June 30, 2022, were $617,000 and $972,000, an increase of $434,000 and $698,000, from the same periods in 2021. In the second quarter of 2022, this subsidiary generated a net operating income of $56,000, compared to a net operating loss of $190,000 in the same period of 2021.

      Commercial and developmental highlights

      First PFAS customer - the company recently secured its first PFAS customer. As part of this project, BioLargo will engineer a comprehensive PFAS mitigation plan for an industrial site, and has signed an agreement with a new channel partner to sell the company's PFAS treatment equipment and engineering services.
      Ikigai's POOPH - The company's white-label pet odor control product partnership with Ikigai is advancing well and generating increasing revenues both from manufacturing the product and from license royalties. Sales thus far have exceeded early expectations, and the company's partners at Ikigai are confident that growth will continue, especially as they push to get the product onto shelves at major retailers.
      Garratt-Callahan partnership - The company expects first sales of the "minimal liquid discharge" (MLD) wastewater treatment equipment developed in partnership with Garratt-Callahan to begin soon, following discussions with an expanding list of Garratt-Callahan customers.
      Larger engineering projects - In this quarter, BioLargo Engineering, Science & Technologies executed engineering projects for new customers, including its project to develop prototypes with Ultra Safe Nuclear, and the waste-to-energy plant project in South America. With both of these projects, early phase work is nearly done, and management anticipates that additional phases will soon begin, with the scope of work and level of engagement expanding.…
      Biolargo | 0,185 $

      Trading Spotlight

      NuGen Medical Devices
      0,162EUR +17,39 %
      NuGen Medical: Kurs hebt ab! mehr zur Aktie »
      schrieb am 06.08.22 00:46:33
      Beitrag Nr. 121 ()

      August 3, 2022 2:30 PM
      BioLargo Sets New Quarterly Revenue Record
      Quarterly Revenues in Q2 Grew 37% Compared to Q1, and 185% Compared to Q2 of 2021…

      BioLargo says it will report record quarterly revenue, with more record quarters to follow
      August 4, 2022
      BioLargo Inc CEO Dennis Calvert says a 37% quarter-over-quarter increase in second-quarter revenue to around $1.3 million is "the culmination of a lot of work".
      "It really is the moment in which we are seeing some pretty dramatic percentage increases," Calvert told Proactive.
      In part, Calvert attributed the quarterly gains to expanded sales of pet control products and wastewater treatment technologies.
      "The number are getting more and more ... meaningful," he added. "Two of our operating units we reported on last quarter were teetering on profitability. We're pretty sure we've now achieved that objective."

      Biolargo | 0,185 $
      schrieb am 20.06.22 20:30:00
      Beitrag Nr. 120 ()
      Sequire Spotlight Presents Biolargo (BLGO): Solutions that Make Life and the Environment Better
      June 15, 2022

      CEO & President, Dennis Calvert, unveils their massive expansion in tackling some of the largest problems facing the environment.

      Biolargo | 0,171 $
      schrieb am 15.06.22 20:13:34
      Beitrag Nr. 119 ()
      Proactive ONE2ONE #Virtual#Investor Forum - Tuesday 14th June 2022
      June 14, 2022
      BLGO starts at 58:07 minutes

      Biolargo | 0,180 $
      schrieb am 07.06.22 20:50:59
      Beitrag Nr. 118 ()
      At least 12 military bases contaminating water supply with toxic PFAS
      Testing by the Department of Defense revealed dangerous levels of the contaminants, drawing concern from public health advocates
      6 Jun 2022…

      Biolargo | 0,194 $
      schrieb am 03.06.22 18:29:38
      Beitrag Nr. 117 ()
      Aus der heutigen shareholder meeting presentation. Zu den bisherigen ausichtsreichen Business Opportunities kommen weitere hinzu :)…

      Biolargo | 0,205 $
      • 1
      • 13
       DurchsuchenBeitrag schreiben

      Investoren beobachten auch:

      WertpapierPerf. %

      Neues aus der Redaktion

      17.05.23 · Accesswire · Biolargo
      17.05.23 · Accesswire · Biolargo
      03.04.23 · Accesswire · Biolargo
      29.03.23 · Accesswire · Biolargo
      22.03.23 · Accesswire · Biolargo
      20.03.23 · Accesswire · Biolargo
      16.03.23 · Accesswire · Biolargo
      20.02.23 · Accesswire · Biolargo
      24.01.23 · Accesswire · Biolargo
      09.01.23 · Accesswire · Biolargo
      BioLargo (BLGO) – environmental solutions provider